Mom Sues over Zofran Heart Birth Defect

In Louisiana, Alexis Alexander is the latest to file a lawsuit against GlaxoSmithKline (GSK) for birth defects caused by its drug Zofran (ondansetron). Her son was born with atrial septic defect, a hole in the heart, after she took Zofran for morning sickness during pregnancy. He has had two surgeries to correct the problem and may have to have more surgery in the future. If you took this dangerous drug during pregnancy and you child was born with birth defects you may be entitled to substantial compensation that can pay for your child’s medical care and other needs.

Atrial Septic Defect

Several studies have linked Zofran use in pregnancy to an increased risk of birth defects, including septal heart defects. Atrial septal heart defect (ASD) is a hole between the upper chambers of the heart. In some babies the hole will close on its own, if it was a small hole to begin with. When it does not close on its own it must be corrected surgically or it can cause long-term damage to the heart and lungs.

ASD can be corrected with open heart surgery in which the surgeons directly closes the hole by sewing it closed with sutures or, if the hole is larger, closes it with a patch. More often a transcatheter device is used. A long, thin tube is inserted in an artery in the groin and used to deliver the device to the heart where it closed the ASD.

If your child was born with atrial septal defect or another birth defect after you took Zofran in pregnancy, please contact an experienced defective drug attorney right away.

Dialysis Patients at Risk of Heart Attack from GranuFlo and NaturaLyte

If you have received dialysis treatment for kidney failure, and have suffered a heart attack or other heart problems, GranuFlo® and NaturaLyte® acid concentrate may be to blame. GranuFlo® and NaturaLyte® are not medicines you take at home, they are used in hemodialysis clinics during treatment and you may not know if these products were used during your treatment. If you suspect that your heart attack or the loss of a loved one was caused by GranuFlo® or NaturaLyte®, please talk to our Louisiana drug recall attorneys today to learn more.

GranuFlo® & NaturaLyte® Injuries and Death

GranuFlo® and NaturaLyte® dosing errors in hemodialysis can lead to:

  • Low blood pressure
  • Cardiac arrhythmia
  • Low blood pressure
  • Low potassium in the blood (hypokalemia)
  • Too little oxygen in the blood (hypoxemia)
  • Too much carbon dioxide in the blood (hypercapnia)
  • Stroke
  • Heart attack
  • Cardiopulmonary arrest
  • Sudden cardiac death

According to Fresenius Medical Care (FMC), maker of GranuFlo® and NaturaLyte® and operator of the largest chain of dialysis clinics in the U.S., 941 dialysis patients had heart attacks in its clinics just in 2010.

If you are a dialysis patient who has suffered a heart attack in Louisiana, and believe that your injuries may have been caused by GranuFlo® or NaturaLyte®, please contact our Louisiana drug recall attorneys today. You may be entitled to compensation for your injuries or for the wrongful death of a loved one caused by these dangerous products.

Johnson and Johnson Discontinuing Sales or Transvaginal Mesh

Johnson & Johnson (J&J) says it will discontinue sales of four of its transvaginal mesh products over the next several months. The company, along with several other device makers, is facing hundreds of lawsuits due to serious complications and injuries linked to the defective mesh. If you have been injured by J&J mesh or any other vaginal mesh product, please talk to our Louisiana drug recall attorneys right away.


Affected Products

J&J says it has asked the U.S. Food and Drug Administration (FDA) for permission to phase out sales of the following vaginal mesh products:


  • Gynecare Prolift
  • Gynecare Prolift+M
  • Gynecare TVT Secur
  • Gynecare Prosima

It has also asked to keep selling its Gynecare Gynemesh product, but with changes to the label restricting its use to abdominal, rather than transvaginal, placement only.


Not a Recall

J&J is not recalling units which have already been sold or implanted. The company says that the products are perfectly safe, and that the decision to discontinue sales is due to changes in commercial viability of the mesh. It plans to phase out sales, worldwide, over the next three to nine months and hopes to complete the process by the first quarter of 2013.

If you are a resident of Louisiana and have been harmed by defective vaginal mesh or lost a loved one to this dangerous medical device, please contact our Louisiana defective drug attorneys at 1-877-LOSS-RECOVER (567-7732). Our qualified and successful product liability lawyers will get you the money you deserve, so call our law firm today.